User profiles for Sudeep Gupta

Sudeep Gupta

Director, ACTREC and Professor of Medical Oncology, Tata Memorial Centre, Mumbai
Verified email at actrec.gov.in
Cited by 17329

[PDF][PDF] Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous …

S Gupta, A Maheshwari, P Parab… - Journal of Clinical …, 2018 - researchgate.net
Purpose We compared the efficacy and toxicity of neoadjuvant chemotherapy followed by
radical surgery versus standard cisplatin-based chemoradiation in patients with locally …

Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial

…, S Siddique, A Budrukkar, I Mittra, S Gupta - The lancet …, 2015 - thelancet.com
Background The role of locoregional treatment in women with metastatic breast cancer at
first presentation is unclear. Preclinical evidence suggests that such treatment might help the …

Identifying the best machine learning algorithms for brain tumor segmentation, progression assessment, and overall survival prediction in the BRATS challenge

…, T Grosges, Y Guan, S Guo, S Gupta… - arXiv preprint arXiv …, 2018 - arxiv.org
Gliomas are the most common primary brain malignancies, with different degrees of
aggressiveness, variable prognosis and various heterogeneous histologic sub-regions, ie, …

[HTML][HTML] Elective versus therapeutic neck dissection in node-negative oral cancer

…, R Vaish, N Kapre, M Dandekar, S Gupta… - … England Journal of …, 2015 - Mass Medical Soc
Background Whether patients with early-stage oral cancers should be treated with elective
neck dissection at the time of the primary surgery or with therapeutic neck dissection after …

Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical cancer (PARCER): a randomized controlled trial

S Chopra, S Gupta, S Kannan, T Dora… - Journal of Clinical …, 2021 - ingentaconnect.com
PURPOSE Postoperative Adjuvant Radiation in Cervical Cancer (PARCER), a phase III
randomized trial, compared late toxicity after image-guided intensity-modulated radiotherapy (IG-…

[HTML][HTML] ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary …

…, S Rowley, M MacKenzie, L Berkman, S Gupta… - Contemporary clinical …, 2016 - Elsevier
Background There is a considerable body of pre-clinical, epidemiological and randomised
data to support the hypothesis that aspirin has the potential to be an effective adjuvant cancer …

A randomized phase 2 study of ADXS11-001 Listeria monocytogenes–Listeriolysin O immunotherapy with or without cisplatin in treatment of advanced cervical cancer

P Basu, A Mehta, M Jain, S Gupta… - International Journal of …, 2018 - ijgc.bmj.com
Objectives A global unmet medical need exists for effective treatments for persistent,
recurrent, or metastatic cervical cancer, as patients have a short life expectancy. Recently, …

Cisplatin chemoradiotherapy vs radiotherapy in FIGO stage IIIB squamous cell carcinoma of the uterine cervix: a randomized clinical trial

…, J Ghosh, J Bajpai, L Gurram, S Gulia, S Gupta - JAMA …, 2018 - jamanetwork.com
Importance The evidence for concurrent chemoradiotherapy (CT-RT) in International Federation
of Gynecology and Obstetrics (FIGO) stage IIIB squamous cell carcinoma of the uterine …

Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai

I Mittra, GA Mishra, RP Dikshit, S Gupta, VY Kulkarni… - bmj, 2021 - bmj.com
Objective To test the efficacy of screening by clinical breast examination in downstaging
breast cancer at diagnosis and in reducing mortality from the disease, when compared with no …

[HTML][HTML] Overall survival prediction in glioblastoma with radiomic features using machine learning

U Baid, SU Rane, S Talbar, S Gupta… - Frontiers in …, 2020 - frontiersin.org
Glioblastoma is a WHO grade IV brain tumor, which leads to poor overall survival (OS) of
patients. For precise surgical and treatment planning, OS prediction of glioblastoma (GBM) …